IRF9 Rekombinanter Antikörper
IRF9 Rekombinant Antikörper für WB, IHC, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
WB, IHC, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
242772F12
Kat-Nr. : 85160-2-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
85160-2-PBS bindet in WB, IHC, Indirect ELISA IRF9 und zeigt Reaktivität mit human
Getestete Reaktivität | human |
Wirt / Isotyp | Kaninchen / IgG |
Klonalität | Rekombinant |
Typ | Antikörper |
Immunogen | IRF9 fusion protein Ag5365 |
Vollständiger Name | IRF 9 |
Berechnetes Molekulargewicht | 393 aa, 44 kDa |
Beobachtetes Molekulargewicht | 44-48 kDa |
GenBank-Zugangsnummer | BC035716 |
Gene symbol | IRF9 |
Gene ID (NCBI) | 10379 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Protein-A-Reinigung |
Lagerungspuffer | PBS only |
Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
IRF9 also named ISGF3 is a transcription regulatory factor that mediates signaling by type I IFNs (IFN-alpha and IFN-beta). Following type I IFN binding to cell surface receptors, Jak kinases (TYK2 and JAK1) are activated, leading to tyrosine phosphorylation of STAT1 and STAT2. The phosphorylated STATs dimerize, associate with IRF9/ISGF3G to form a complex termed ISGF3 transcription factor, that enters the nucleus. ISGF3 binds to the IFN stimulated response element (ISRE) to activate the transcription of IFN stimulated genes, which drive the cell in an antiviral state.